At Fall Clinical 2026, Joel Gelfand, MD, MSCE, reviewed GLP-1 candidacy, weight conversations, and an upcoming monotherapy ...
A Japanese case report of co-localized psoriasis and vitiligo reveals that IL-23 blockade cleared psoriasis but not vitiligo, ...
The financing round, led by investment firm Pekron, Investcorp-backed Sanos Group, Icelandic investment company Kaldbakur and Landvættir, an Icelandic ...
<?xml encoding="utf-8" ?> Arcutis Biotherapeutics, Inc. ARQT stock traded higher Thursday after Cantor Fitzgerald initiated ...
While dermatologists prescribe coal tar shampoos for specific scalp conditions, it’s important to understand when and how ...
The real problem lies in how social media reduces an intricate endocrine system to a crude algorithm: stress equals spiked ...
This episode, "Efficacy and Safety Data for Emerging Oral HS Agents," has Chao presenting the latest trial results for ...
Zasocitinib demonstrated superiority over deucravacitinib for the treatment of moderate to severe plaque psoriasis, according ...
No. 21 / 2026Zealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ...
PRNewswire/ -- (NYSE: JNJ) today announced new two-year results from the Phase 3 ICONIC-LEADa study evaluating ICOTYDE® (icotrokinra), ...
Introduction: Skin diseases also affect the mindI'm so itchy that I can't sleep at night.I'm so self-conscious about my acne that I don't want to face people.My child's eczema won't get better, and ...
Psoriasis is often called a skin condition, which is a bit like calling a house fire a smoke problem. It is an immune disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results